期刊文献+

环己酮二乙缩酮的合成工艺研究 被引量:6

Studies on Synthesis of Cyclohexanone Diethyl Acetal
在线阅读 下载PDF
导出
摘要 环己酮二乙缩酮广泛应用于医药中间体的合成,也可以用于合成1-乙氧基环己烯,继而用于合成高分子材料和医药中间体。其制备方法是以氯化铵为催化剂,原甲酸三乙酯为解水剂,由无水乙醇和环己酮缩合合成。此方法具有催化剂便宜易得,可回收,反应后处理方便,工业三废少,收率高等优点,是环境友好的清洁生产过程。今通过各种影响因素研究实验得出了合成的最佳工艺条件:环己酮用量为29.4g(0.3mol)时,环己酮与原甲酸三乙酯摩尔比1:1.2,环己酮与无水乙醇摩尔比1:3,催化剂0.006mol,回流下反应,反应时间90min,产品收率91.8%,产品纯度和结构由气相色谱、气质联用仪及核磁共振仪确定。 Cyclohexanone diethyl acetal is widely used as pharmaceutical intermediates, and it may be pyrolyzed to give 1-ethoxy cyclohexene which could be used in synthesizing both polymer material and pharmaceutical intermediates. Cyclohexanone diethyl acetal was prepared from cyclohexanone with anhydrous ethanol as reactant, ammonium chloride as catalyst, triethyl orthoformate as water scavenger. The proposed method, which is preferable for green process, has many advantages such as the catalyst used is cheap and easily obtained, the post treatment of the process is convenient, the process has few industrial waste and high yield, etc. The suitable technical conditions were investigated in detail, which include the effects of catalyst, reaction time and reactants mole ratio on yield. The results indicate that 91.8% yield could be obtained with the following optimal reaction conditions: cyclohexanone weight 29.4 g (0.3 mol), the mole ratio of cyclohexanone and triethyl orthoformate 1: 1.2, the mole ratio of cyclohexanone and anhydrous ethanol 1: 3, the reaction time 90 minutes, the amount of catalyst 0.006 mole, and reaction with reflux. The purity and structure of the product was examined by GC GC-MS and NMR.
出处 《高校化学工程学报》 EI CAS CSCD 北大核心 2006年第1期90-93,共4页 Journal of Chemical Engineering of Chinese Universities
基金 国家自然科学基金资助项目(20376072)。
关键词 环己酮 原甲酸三乙酯 环己酮二乙缩酮 无水氯化铵 反应条件优化 cyclohexanone triethyl orthoformate cyclohexanone diethyl acetal anhydrous ammonium chloride optimization
  • 相关文献

参考文献12

  • 1Nishi takehide. Takemoto Toshiyasu. Medicine composition containing aminoalcohol derivative [P]. JP, 2003, 267, 974. 2003-09-25.
  • 2Martin Quibell, Steven Taylor, Magnus N, et al. Cysteine protease inhibitors [P]. USP: 2003, 203,900. 2003-10-30.
  • 3Bucchignano James J, Yorktown, Huang Wu-song, Katanani Ahmad D. E-beam application to mask making using new improved krs resist [P]. USP: 2000, 6, 037, 097. 2000-03-14.
  • 4Oskar N, R Benedikt Raether. Reactivities of substituted acyclic and cyclic enolethers in photoinduced cationic polymerization [J].Macromol Chem Phys, 1998, 199(2): 191-196.
  • 5梁建华,邓志华,孙京国,林美娜,姚国伟.红霉素A9-肟羟基的醚化保护[J].北京理工大学学报,2003,23(1):120-122. 被引量:5
  • 6Martin-lomas, Mannel, Marea F, et al. Inositol-containing Hexasaccarides, Their synthesis and their uses [P]. WO: 0039, 141.2000-06-07.
  • 7Manuel M L, Maria F M, Luis C J. Attempted synthesis of type-A inositol phosphoglycan mediators-synthesis of a pseudohexasaccharide precursor [J]. Eur J Org Chem, 2000, 2000(8):1547-1572.
  • 8戴立言,陈英奇,吴兆立.替马沙星中间体7-氯-6-氟-1-(2,4-二氟苯基)-1,4-二氢-4-氧-3-喹啉羧酸合成方法的改进[J].高校化学工程学报,2001,15(5):468-471. 被引量:3
  • 9Melvyn R L, David G C, Huynh MH, et al. Synthesis and crystal structures of two potential gemdi(pyraz-olyl)cycloalkane ligands,[C6H10(C3N2H3)2] and [C5H8(C3N2H3)2] [J]. Journal of Chem Crys, 1999, 129(6): 659-661.
  • 10Ott G M, Ramos T, Grand D et al. A versatile rhodium catalyst for acetalization reactions under mild conditions [J]. Tetrahedron Letters, 1989, 30(45): 6151-6154.

二级参考文献12

  • 1Chu D T W,J Med Chem,1991年,34卷,168页
  • 2Omura S, Tanaka H. Macrolide antibiotics, chemistry, biology and practice[M]. New York: Academic Press, 1984.
  • 3Kurath P, Jones P H, Egan R S, et al. Acid degradation of erythromycin A and erythromycin B[J]. Experienta, 1971,27(4):362.
  • 4Atkins P J, Herbert T O, Jonse N B. Kinetic studies on the decomposition of erythromycin A in aqueous acidic and natural buffers[J]. Int J Pharm, 1986,30:199-207.
  • 5Morimoto S, Takahashi Y, Watanabe Y, et al. Chemical modification of erythromycins[J]. J Antibiot, 1984,37:187.
  • 6Watanabe Y, Morimoto S, Adachi T, et al. Chemical modification of erythromycins[J]. J Antibiot, 1993,46:647.
  • 7Watanabe Y, Morimoto S, Omura S. Novel erythromycin compounds[P].USP:4331803,1982-05-25.
  • 8Watanabe Y, Morimoto S, Goi M, et al. Method for selective methylation of erythromycin A derivatives[P]. USP: 4672109, 1987-06-09.
  • 9Morimoto S, Matsunaga T, Adachi T, et al. Erythromycin A derivatives and method for the preparation of the same[P]. EP: 0272110, 1987-12-16.
  • 10王金南.抗生素[M]. 北京:中国医药科技出版社,1999.109-111.Wang Jinnan. Antibiotics[M]. Beijing: China Medicine Science and Technology Publishing House, 1999.109-111.(in Chinese)

共引文献6

同被引文献48

引证文献6

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部